NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 88 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2014. The put-call ratio across all filers is 110.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $552,000 | +44.1% | 3,993,920 | +7.1% | 0.00% | – |
Q4 2018 | $383,000 | -67.4% | 3,727,812 | -26.8% | 0.00% | – |
Q3 2018 | $1,174,000 | +1.1% | 5,095,363 | +0.2% | 0.00% | – |
Q2 2018 | $1,161,000 | -37.3% | 5,083,504 | -1.1% | 0.00% | – |
Q1 2018 | $1,851,000 | -0.1% | 5,141,883 | -0.5% | 0.00% | – |
Q4 2017 | $1,853,000 | -9.2% | 5,170,273 | +5.1% | 0.00% | – |
Q3 2017 | $2,041,000 | -18.1% | 4,917,535 | +0.6% | 0.00% | – |
Q2 2017 | $2,492,000 | -10.1% | 4,887,743 | +1.7% | 0.00% | – |
Q1 2017 | $2,773,000 | -3.1% | 4,807,244 | +5.6% | 0.00% | – |
Q4 2016 | $2,862,000 | -28.6% | 4,554,028 | +3.9% | 0.00% | – |
Q3 2016 | $4,011,000 | +69.8% | 4,381,100 | -1.6% | 0.00% | – |
Q2 2016 | $2,362,000 | -48.5% | 4,451,291 | -8.3% | 0.00% | – |
Q1 2016 | $4,583,000 | -28.9% | 4,851,875 | +0.2% | 0.00% | – |
Q4 2015 | $6,443,000 | -40.9% | 4,844,212 | +1.3% | 0.00% | – |
Q3 2015 | $10,905,000 | +48.1% | 4,782,586 | +4.6% | 0.00% | – |
Q2 2015 | $7,361,000 | +2.5% | 4,571,668 | +1.3% | 0.00% | – |
Q1 2015 | $7,178,000 | -9.8% | 4,514,718 | +7.2% | 0.00% | -100.0% |
Q4 2014 | $7,960,000 | +46.2% | 4,211,742 | +2.1% | 0.00% | – |
Q3 2014 | $5,444,000 | -12.8% | 4,124,269 | -2.2% | 0.00% | – |
Q2 2014 | $6,242,000 | -17.2% | 4,217,943 | +3.5% | 0.00% | -100.0% |
Q1 2014 | $7,542,000 | -7.5% | 4,076,429 | +3.5% | 0.00% | 0.0% |
Q4 2013 | $8,155,000 | -19.3% | 3,939,767 | +3.2% | 0.00% | 0.0% |
Q3 2013 | $10,111,000 | +21.0% | 3,815,835 | +22.0% | 0.00% | 0.0% |
Q2 2013 | $8,354,000 | – | 3,128,847 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |